Document is current

Article History

Received: 25 May 2025

Revised: 25 May 2025

Accepted: 19 June 2025

First Online: 6 August 2025

Compliance with ethical standards

:

: The scientific guarantor of this publication is Professor Shonit Punwani.

: The authors of this manuscript declare relationships with the following companies: F.G. reports consulting fees from SpectraCure and Procept outside of the submitted work. He has received speaker fees from Bayer and Siemens. He is a member of the Scientific Editorial Board of European Radiology (section: urogenital). As such, they have not participated in the selection or review processes for this article. S.P. reports consulting fees from NVISION IMAGING, Gold Standard Phantoms and Quibim outside of the submitted work. The remaining authors declare no conflicts of interest. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: One of the authors (T.P.) has significant statistical expertise.

: Written informed consent was obtained from all subjects (patients) in this study.

: Institutional Review Board approval was obtained. Ethical approval was granted by the London—Stanmore Research Ethics Committee, Health Research Authority (ref: 19/LO/1129).

: Participants from the ReIMAGINE Screening Study have been included in a previous publication. Primary outcomes were reported in Moore et al [ ] . In addition, the study protocol has been previously published in Marsden et al [ ] .

: